TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage

May 22, 2020

TriNetX is partnering with the FDA’s Sentinel Operations Center at the Harvard Pilgrim Health Care Institute (HPHCI) to monitor priority drugs used for treating hospitalized COVID-19 patients.

The institute is using TriNetX's de-identified COVID-19 clinical data set to support studies for monitoring sedatives and other drugs used to assist with respiratory disease and other coronavirus-related conditions.  

The projects will look at inpatient and outpatient drug use to identify usage patterns that could signal possible drug shortages.

View today's stories